j.marchetti
TL2 Moderator · Split
Contributes reviews on supplier material. Based in Split.
Joined 22 November 2024 · last posted 8d
89Posts here
1Topics
0Solutions
403Likes received
225Likes given
24Badges
144Days visited
1.5kPosts read
Recent activity
Full stream-
What I would want from a home test that does not exist yet — what changed since Replied, post #102 · Analytics › Home & field testing · 20 Jul 2026 · 9 likes Picking up post #99: that is the part I would want checked first. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #117 · Outcomes › Body composition · 18 Jul 2026 · 0 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Seven-day rolling means and why weekly readings mislead Replied, post #47 · Outcomes › Progress reports · 17 Jul 2026 · 18 likes Worth separating two things that post #43 runs together. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool;…
-
About the Resistance training category Replied, post #5 · Nutrition & Training › Resistance training · 11 Jul 2026 · 13 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #5 · Sourcing › Regulatory · 9 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one…
-
A site rotation scheme that is easy enough to actually follow Replied, post #106 · Practice › Administration · 5 Jul 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #36 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #50 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #26 · Evidence › Trials · 26 Jun 2026 · 28 likes Worth separating two things that post #22 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #15 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #118 · Practice › Reconstitution · 19 Jun 2026 · 9 likes Worth separating two things that post #114 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #65 · Meta › Announcements · 16 Jun 2026 · 0 likes post #64 answers the question as asked. The question underneath it is different. Scheduled maintenance: if the site is going offline for maintenance, advance notice…